» Articles » PMID: 7195481

Depression, Intellectual Impairment, and Parkinson Disease

Overview
Journal Neurology
Specialty Neurology
Date 1981 Jun 1
PMID 7195481
Citations 101
Authors
Affiliations
Soon will be listed here.
Abstract

To determine the prevalence of depression in Parkinson disease (PD) we evaluated 55 consecutive patients without dementia and 31 of their spouses. All subjects completed the Beck depression inventory and a quantitative mini-mental state examination. Using the Beck criteria, 47% of the patients and 12% of the spouses rated themselves as significantly depressed. Mental state scores were significantly lower in the patients. There was a correlation between the severity of depression and cognitive impairment, particularly for calculation, digit span, and visuomotor skills. The severity of parkinsonism, particularly bradykinesia, also paralleled cognition. There was a slight but significant relationship between parkinsonism and depression. These results confirm the high incidence of depression in PD, and suggest that depression in Parkinson patients may be accompanied by mild intellectual impairment and inattention which is independent of the severity of the illness.

Citing Articles

Lab-made disposable screen-printed electrochemical sensors and immunosensors modified with Pd nanoparticles for Parkinson's disease diagnostics.

Orzari L, Silva L, de Freitas R, Brazaca L, Janegitz B Mikrochim Acta. 2024; 191(1):76.

PMID: 38172448 DOI: 10.1007/s00604-023-06158-3.


The role of neurotransmitter systems in mediating deep brain stimulation effects in Parkinson's disease.

Alosaimi F, Boonstra J, Tan S, Temel Y, Jahanshahi A Front Neurosci. 2022; 16:998932.

PMID: 36278000 PMC: 9579467. DOI: 10.3389/fnins.2022.998932.


Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for Treatment.

Prange S, Klinger H, Laurencin C, Danaila T, Thobois S Drugs Aging. 2022; 39(6):417-439.

PMID: 35705848 PMC: 9200562. DOI: 10.1007/s40266-022-00942-1.


Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson's Disease.

Antipova V, Holzmann C, Hawlitschka A, Witt M, Wree A Toxins (Basel). 2021; 13(7).

PMID: 34357977 PMC: 8310221. DOI: 10.3390/toxins13070505.


Validation and demonstration of a new comprehensive model of Alzheimer's disease progression.

Stern Y, Stallard E, Kinosian B, Zhu C, Cosentino S, Jin Z Alzheimers Dement. 2021; 17(10):1698-1708.

PMID: 33991041 PMC: 8818260. DOI: 10.1002/alz.12336.